
-
Dynavax's Evolving Business Model2/9/2024
Dynavax found a new revenue stream during COVID, and a way to grow market share in the absence of a market. Ryan Spencer describes the ups and downs, and his own journey to CEO role.
-
Where Are They Now? Ono Pharmaceuticals2/5/2024
Ono Pharmaceuticals continues its quest to become a global biopharmaceutical company, after discovering and helping to launch one of the most successful cancer drugs, Opdivo, in the last decade.
-
Innovation From Animals And Evolution2/1/2024
Insights gleaned from a variety of animal species, and a deeper understanding of evolution aided by artificial intelligence, could help bring a new wave of therapies to market.
-
That Price Is WAC: Boehringer's Push For Access To Humira Biosimilars1/29/2024
Boehringer Ingelheim's biosimilar commercial brand leader explains the company's two-tier pricing approach with Cyltezo, an interchangeable Humira biosimilar, and what new FDA guidance on interchangeability means for patients and physicians.
-
Pharmaceutical Scientists' Salaries in 20231/15/2024
The 2023 AAPS survey of pharmaceutical scientists' salaries showed a 6.7% jump over 2022, but the industry has work to do on closing the gender gap.
-
Where Are They Now? Roivant1/15/2024
"Where Are They Now?" looks back, and forward, at companies and executives previously covered in Life Science Leader magazine.
-
CEO Q&A: David Younger, Ph.D.1/5/2024
Life Science Leader catches up with David Younger, co-founder and CEO of A-Alpha Bio, about the promise of molecular glues, the challenges of starting up a new company, and collaborating with Big Pharma.
-
Ahead Of The Curve On Radiopharmaceuticals1/1/2024
Former president of Cardinal Health’s nuclear and precision health solutions group Tiffany Olson discusses her work on Bayer's Xofigo, and how she anticipated the rise of radiopharmaceuticals.
-
A New Year At Life Science Leader1/1/2024
Life Science Leader wishes you a happy New Year and announces plans for 2024.